Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience

BHSRX BlackRock Health Sciences Opps R

  • Fund
  • BHSRX
  • Price as of: Sep 20, 2019
  • $58.66 + $0.29 + 0.50%

BHSRX - Profile

Vitals

  • YTD Return 11.8%
  • 3 Yr Annualized Return 6.5%
  • 5 Yr Annualized Return 4.0%
  • Net Assets $7.07 B
  • Holdings in Top 10 40.4%

52 WEEK LOW AND HIGH

$58.66
$49.05
$63.21

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.46%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 39.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

STANDARD (TAXABLE)

$100

IRA

$100

Fund Classification

PRIMARY CATEGORY

  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return 11.8%
  • 3 Yr Annualized Total Return 8.7%
  • 5 Yr Annualized Total Return 6.6%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.20%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name BlackRock Health Sciences Opportunities Portfolio
  • Fund Family Name BlackRock
  • Inception Date Sep 12, 2011
  • Shares Outstanding N/A
  • Share Class Retirement
  • Currency USD
  • Domiciled Country United States
  • Manager Erin Xie

Fund Description

The fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies in health sciences and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It will concentrate its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries.

BHSRX - Performance

Return Ranking - Trailing

Period BHSRX Return Category Return Low Category Return High Rank in Category (%)
YTD 11.8% -0.7% 20.3% 46.85%
1 Yr -5.7% -27.9% 1.0% 23.85%
3 Yr 6.5%* -16.4% 14.0% 21.36%
5 Yr 4.0%* -11.2% 14.3% 14.58%
10 Yr N/A* -2.6% 14.0% N/A

* Annualized


Return Ranking - Calendar

Period BHSRX Return Category Return Low Category Return High Rank in Category (%)
2018 -0.2% -25.3% 21.5% 18.10%
2017 20.0% -10.8% 43.9% 41.75%
2016 -8.6% -31.6% 6.9% 17.00%
2015 -2.1% -20.4% 13.8% 52.04%
2014 20.2% -5.8% 31.5% 34.78%

Total Return Ranking - Trailing

Period BHSRX Return Category Return Low Category Return High Rank in Category (%)
YTD 11.8% -0.7% 20.3% 46.85%
1 Yr -5.7% -27.9% 2.0% 31.19%
3 Yr 8.7%* -16.4% 15.7% 16.50%
5 Yr 6.6%* -11.2% 17.6% 27.08%
10 Yr N/A* -2.6% 17.1% N/A

* Annualized


Total Return Ranking - Calendar

Period BHSRX Return Category Return Low Category Return High Rank in Category (%)
2018 -0.2% -25.3% 22.2% 26.67%
2017 24.3% -10.8% 45.8% 24.27%
2016 -6.4% -24.2% 8.7% 15.00%
2015 -2.1% -16.6% 15.2% 67.35%
2014 28.3% -5.8% 36.7% 27.17%

NAV & Total Return History

BHSRX - Holdings

Concentration Analysis

BHSRX Category Low Category High BHSRX % Rank
Net Assets 7.07 B 2.54 M 43.3 B 8.26%
Number of Holdings 117 30 390 9.09%
Net Assets in Top 10 2.88 B 604 K 17.9 B 9.92%
Weighting of Top 10 40.43% 23.0% 74.6% 48.76%

Top 10 Holdings

  1. UnitedHealth Group Inc 8.01%

  2. Abbott Laboratories 6.77%

  3. Boston Scientific Corp 4.15%

  4. Thermo Fisher Scientific Inc 3.52%

  5. Stryker Corp 3.47%

  6. Medtronic PLC 3.38%

  7. Merck & Co Inc 3.15%

  8. Anthem Inc 2.80%

  9. Edwards Lifesciences Corp 2.73%

  10. Zoetis Inc Class A 2.44%


Asset Allocation

Weighting Return Low Return High BHSRX % Rank
Stocks
95.46% 78.78% 100.00% 75.21%
Cash
3.64% 0.00% 21.10% 31.40%
Other
0.90% -4.27% 3.81% 16.53%
Preferred Stocks
0.00% 0.00% 2.47% 91.74%
Convertible Bonds
0.00% 0.00% 0.18% 88.43%
Bonds
0.00% 0.00% 0.20% 89.26%

Stock Sector Breakdown

Weighting Return Low Return High BHSRX % Rank
Healthcare
93.08% 63.42% 99.67% 66.12%
Technology
1.26% 0.00% 22.28% 49.59%
Basic Materials
0.58% 0.00% 1.35% 18.18%
Consumer Defense
0.54% 0.00% 1.58% 5.79%
Utilities
0.00% 0.00% 0.00% 88.43%
Real Estate
0.00% 0.00% 1.71% 90.08%
Industrials
0.00% 0.00% 3.11% 89.26%
Financial Services
0.00% 0.00% 6.30% 91.74%
Energy
0.00% 0.00% 0.31% 88.43%
Communication Services
0.00% 0.00% 2.11% 88.43%
Consumer Cyclical
0.00% 0.00% 5.27% 94.21%

Stock Geographic Breakdown

Weighting Return Low Return High BHSRX % Rank
US
86.96% 60.36% 99.29% 23.14%
Non US
8.50% 0.00% 39.22% 74.38%

BHSRX - Expenses

Operational Fees

BHSRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.46% 0.10% 4.94% 41.28%
Management Fee 0.68% 0.09% 1.30% 53.72%
12b-1 Fee 0.50% 0.00% 1.00% 62.50%
Administrative Fee 0.06% 0.01% 0.40% 28.57%

Sales Fees

BHSRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 2.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

BHSRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 0.75% 2.00% N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

BHSRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 39.00% 0.00% 341.00% 54.46%

BHSRX - Distributions

Dividend Yield Analysis

BHSRX Category Low Category High BHSRX % Rank
Dividend Yield 0.00% 0.00% 1.21% 95.04%

Dividend Distribution Analysis

BHSRX Category Low Category High Category Mode
Dividend Distribution Frequency Annually Annually Annually Annually

Dividend Payout History


Net Income Ratio Analysis

BHSRX Category Low Category High BHSRX % Rank
Net Income Ratio -0.20% -2.24% 1.48% 50.46%

Capital Gain Distribution Analysis

BHSRX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

BHSRX - Managers

Erin Xie

Manager

Start Date

Tenure

Tenure Rank

Jul 31, 2003

16.1

16.1%

Ms. Xie is the managing director and Portfolio Manager of BlackRock Advisor since 2006. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Ms. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.


Tenure Analysis

Category Low

0.25

Category High

21.97

Category Average

9.56

Category Mode

19.35